496 related articles for article (PubMed ID: 23809507)
1. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
2. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
3. Glucose Tolerance in Patients with Cystic Fibrosis - Results from the German Cystic Fibrosis Registry.
Prinz N; Wosniok J; Staab D; Ballmann M; Dopfer C; Regenfuß N; Rosenecker J; Schramm D; W RH; Nährlich L
Klin Padiatr; 2020 Jul; 232(4):210-216. PubMed ID: 32176935
[TBL] [Abstract][Full Text] [Related]
4. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
[TBL] [Abstract][Full Text] [Related]
5. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.
Darukhanavala A; Van Dessel F; Ho J; Hansen M; Kremer T; Alfego D
PLoS One; 2021; 16(4):e0250036. PubMed ID: 33882078
[TBL] [Abstract][Full Text] [Related]
6. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
[TBL] [Abstract][Full Text] [Related]
7. Combined Indeterminate and Impaired Glucose Tolerance Is a Novel Group at High Risk of Cystic Fibrosis-Related Diabetes.
Potter KJ; Reynaud Q; Boudreau V; Racine F; Tremblay F; Lavoie A; Carricart M; Mailhot G; Durieu I; Senior PA; Rabasa-Lhoret R
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3901-e3910. PubMed ID: 34132785
[TBL] [Abstract][Full Text] [Related]
8. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus.
Noronha RM; Damaceno N; Muramatu LH; Monte O; Calliari LE
Pediatr Diabetes; 2014 Jun; 15(4):309-12. PubMed ID: 24256553
[TBL] [Abstract][Full Text] [Related]
9. [Abnormal glucose tolerance in prepubertal patients with cystic fibrosis].
Martín-Frías M; Lamas Ferreiro A; Enes Romero P; Cano Gutiérrez B; Barrio Castellanos R
An Pediatr (Barc); 2012 Nov; 77(5):339-43. PubMed ID: 22743620
[TBL] [Abstract][Full Text] [Related]
10. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
Lek N; Acerini CL
Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
[TBL] [Abstract][Full Text] [Related]
12. Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET).
Coriati A; Ziai S; Azar M; Berthiaume Y; Rabasa-Lhoret R
J Cyst Fibros; 2016 Jan; 15(1):127-32. PubMed ID: 25818059
[TBL] [Abstract][Full Text] [Related]
13. Marginal association of fasting blood glucose with the risk of cystic fibrosis-related diabetes.
Potter KJ; Bonhoure A; Boudreau V; Tremblay F; Lavoie A; Carricart M; Senior PA; Rabasa-Lhoret R
Ann Endocrinol (Paris); 2023 Apr; 84(2):265-271. PubMed ID: 36332698
[TBL] [Abstract][Full Text] [Related]
14. The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes.
Gileles-Hillel A; Soesman LH; Miari S; Breuer O; Tsabari R; Elyashar-Earon H; Armoni S; Sprikkelman AB; Reiter J; Zangen D; Lavi E; Kerem E; Cohen-Cymberknoh M
Pediatr Pulmonol; 2022 Nov; 57(11):2774-2780. PubMed ID: 35999051
[TBL] [Abstract][Full Text] [Related]
15. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis.
Mueller-Brandes C; Holl RW; Nastoll M; Ballmann M
Eur Respir J; 2005 Apr; 25(4):715-7. PubMed ID: 15802348
[TBL] [Abstract][Full Text] [Related]
16. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis.
Brodsky J; Dougherty S; Makani R; Rubenstein RC; Kelly A
Diabetes Care; 2011 Feb; 34(2):292-5. PubMed ID: 21228248
[TBL] [Abstract][Full Text] [Related]
17. Improving screening for cystic fibrosis-related diabetes at a pediatric cystic fibrosis program.
Kern AS; Prestridge AL
Pediatrics; 2013 Aug; 132(2):e512-8. PubMed ID: 23821699
[TBL] [Abstract][Full Text] [Related]
18. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance.
Merjaneh L; He Q; Long Q; Phillips LS; Stecenko AA
J Cyst Fibros; 2015 Jan; 14(1):135-41. PubMed ID: 24998161
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
[TBL] [Abstract][Full Text] [Related]
20. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]